4 news items
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
AAN
AGRI
ALLG
17 Jun 24
cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months
US Stocks Mixed; Dow Tumbles Over 100 Points
ALLG
AVTE
MBIO
17 Jun 24
of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
SCNI
15 May 24
release analysis, which showed significantly reduced IL-17 release (p<0.001) in the human skin in response to treatment with our anti-IL-17 nanoAb
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services
SCNI
8 Apr 24
Scinai's personal customer responsiveness. These initial stages lay the groundwork for a collaborative and productive relationship going forward
- Prev
- 1
- Next